QUOTE AND NEWS
SeekingAlpha  Apr 7  Comment 
Idenix Pharmaceuticals, Inc. (IDIX) Promising Clinical Data Conference Call April 7, 2014 08:00 AM ET Executives Teri Dahlman – Director of Corporate Communications Douglas L. Mayers – EVP and CMO Jacques Dumas – EVP and CSO ...
StreetInsider.com  Apr 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Idenix+Pharma+%28IDIX%29+Updates+on+IDX21437+in+HCV%3B+Plans+mid-2014+Initiation+of+Phase+II+with+Samatasvir/9356663.html for the full story.
newratings.com  Mar 25  Comment 
JERUSALEM (dpa-AFX) - Albany Molecular Research Inc. (AMRI) has agreed to acquire Cedarburg Pharmaceuticals Inc., a contract developer and manufacturer of technically complex active pharmaceutical ingredients, for $38.2 million in cash. The...
SeekingAlpha  Mar 24  Comment 
By Peter Geschek: Idenix Now that Sovaldi, Gilead Sciences (GILD) hepatitis C drug is approved and selling well, a number of companies remember that they have invented the drug. Lawsuits are flying back and forth and patent attorneys are...
StreetInsider.com  Mar 24  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Idenix+Pharma+%28IDIX%29+to+Challenge+Norway+Patent+Decision/9308283.html for the full story.
FierceBiotech  Mar 14  Comment 
Idenix Pharmaceuticals believes Gilead Sciences violated its patents with the blockbuster-selling hepatitis C pill Sovaldi, and the biotech has expanded its legal fight into Europe, angling for a cut of sales.
SeekingAlpha  Mar 13  Comment 
Idenix Pharmaceuticals Inc. (IDIX) 2014 Barclays Global Healthcare Conference Call March 13, 2014 9:30 AM ET Executives Daniella Beckman – Senior Vice President and Chief Financial Officer Analysts Ying Huang – Barclays...
SeekingAlpha  Mar 11  Comment 
By Unconventional Capital Wisdom: In July of last year we wrote a report on Idenix Pharmaceuticals (IDIX) indicating that a small chance of a potential buyout, at historic HCV takeover multiples, could send Idenix shares at least 146% higher. We...
StreetInsider.com  Feb 27  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Idenix+Pharmaceuticals+%28IDIX%29+Tops+Q4+EPS+by+5c/9226624.html for the full story.
Stock Blog Hub  Feb 11  Comment 
At the J.P. Morgan Healthcare Conference in San Francisco three weeks ago, it was all rainbows and unicorns when it came to the biotech sector. At that point, the sector had climbed 50% over the previous year and 140% since the recent low in...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki